PolarityTE, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementPolarityte, Inc. • March 30th, 2021 • Biological products, (no disgnostic substances) • New York
Company FiledMarch 30th, 2021 Industry JurisdictionPolarityTE, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: